Press Release

Akebia Therapeutics to Participate in Upcoming Investor Conferences

May 29, 2019 at 8:00 AM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 29, 2019-- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will participate in the following investor conferences:

  • The Jefferies 2019 Healthcare Conference on Tuesday, June 4th at 3:00 p.m. Eastern Time at the Grand Hyatt New York.
  • The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19th at 10:55 a.m. Eastern Time at the Lotte New York Palace.

A live webcast of the presentations will be available on the company’s website at www.akebia.com. A replay of the webcast will be available on Akebia’s website following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Source: Akebia Therapeutics, Inc.

Kristen K. Sheppard, Esq
VP, Investor Relations
ksheppard@akebia.com

 
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet